KCTD17 binds to C/EBP homologous protein (Chop) to target it for ubiquitin-mediated degradation, which is likely associated with increased adipogenesis99, supporting KCTD17 as a novel therapeutic target for obesity. The gene discussed is KCTD17; the disease is obesity disorder.